Potentiating effect of heparin in the activation of procollagenase by a low-Mr angiogenesis factor.
A low-Mr freely dialysable endothelial cell-stimulating angiogenesis factor (ESAF) from conditioned medium of a mouse lymphoma cell line has previously been shown to activate latent skin fibroblast procollagenase. Activation comparable with the maximum that can be achieved with trypsin is obtained with chemically undetectable amounts of the factor. We now show that when even smaller amounts of ESAF are used heparin is able to potentiate its action in this system. The relationship between this activity and the mechanism of angiogenesis, which is itself potentiated by heparin, is discussed.
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017364:Collagenases; D004357:Drug Synergism; D004789:Enzyme Activation; D004792:Enzyme Precursors / Q000378:metabolism*; D005347:Fibroblasts / Q000201:enzymology; D006133:Growth Substances / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008634:Mersalyl / Q000494:pharmacology; D003012:Microbial Collagenase / Q000378:metabolism*; D008970:Molecular Weight; D012867:Skin / Q000201:enzymology*
D043925:Angiogenesis Inducing Agents; D004792:Enzyme Precursors; D006133:Growth Substances; D008634:Mersalyl; D006493:Heparin; D017364:Collagenases; C022440:procollagenase; D003012:Microbial Collagenase